Conceptual breakthroughs of the long noncoding RNA functional system and its endogenous regulatory role in the

Anyou Wang1

  • 1Feinstone Center for Genomic Research, University of Memphis, Memphis, TN 38152, USA.

Insights

Long noncoding RNAs (lncRNAs), once dismissed as "junk" DNA, are now recognized as crucial regulators in cancer. Big data analysis reveals their central role in cancer

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Research

Background:

  • Long noncoding RNAs (lncRNAs) were historically considered non-functional genomic elements.
  • Recent research indicates lncRNAs possess significant biological functions, yet their roles remain incompletely understood.
  • Existing knowledge is limited by conventional, biased observations from small datasets.

Purpose of the Study:

  • To review big data studies that elucidate the functional system and endogenous regulatory roles of lncRNAs in all cancers.
  • To challenge conventional understanding by highlighting lncRNAs as critical endogenous regulators, distinct from proteins.

Main Methods:

  • Analysis of emerging big data to overcome limitations of traditional, small-scale studies.
  • Focus on studies that re-evaluate lncRNA biology from an unbiased, comprehensive perspective.

Main Results:

  • lncRNAs exhibit unique functional systems, including roles in transcriptional regulation and mitochondrial interaction, with lower energy consumption.
  • lncRNAs are identified as the most critical endogenous regulators of all cancers, surpassing the role of proteins.
  • lncRNAs govern the cancer regulatory network by dominating key modules, acting as hubs and inducers.

Conclusions:

  • Big data approaches provide an unbiased view of lncRNA biology, advancing fundamental principles.
  • lncRNAs are pivotal endogenous regulators in the complex network of all cancers.
  • These findings offer a new framework for understanding the human genome and developing strategies against lncRNA-regulated diseases.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K